Risk Assessment for Different Formulations in a Highly Potent Drug Facility: Oral Solid Dose & Liquid Dosage Formulations
Time: 3:00 pm
day: Day One
Details:
• Understanding how to risk assess cross contamination for OSD or liquid dosage formulations, including parenteral
• Considering how different states of compound influence bioreactor charging and how to navigate this whilst considering the different risks associated with these processes and adapting safety procedures accordingly
• Designing facilities and robust workflow and safety processes to reduce risk of operator exposure in the event of a leak or airborne dust from milling
